Correction: Polygenic risk for triglyceride levels in the presence of a high impact rare variant

Affiliations

• ¹ Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
• ² Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
• ³ Clinical Genetics Research Program, Centre for Addiction and Mental Health, Toronto, ON, Canada.
• ⁴ The Dalglish Family 22Q Clinic, University Health Network, Toronto, ON, Canada.
• ⁵ The Centre for Applied Genomics, The Hospital for Sick Children, Toronto, ON, Canada.
• ⁶ Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
• ⁷ Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, Canada.
• ⁸ Department of Computer Science, University of Toronto, Toronto, ON, Canada.
• ⁹ Institute of Medical Science, University of Toronto, Toronto, ON, Canada. anne.bassett@utoronto.ca.
• ¹⁰ Clinical Genetics Research Program, Centre for Addiction and Mental Health, Toronto, ON, Canada. anne.bassett@utoronto.ca.
• ¹¹ The Dalglish Family 22Q Clinic, University Health Network, Toronto, ON, Canada. anne.bassett@utoronto.ca.
• ¹² Department of Psychiatry, University of Toronto, Toronto, ON, Canada. anne.bassett@utoronto.ca.
• ¹³ Toronto General Hospital Research Institute and Campbell Family Mental Health Research Institute, Toronto, ON, Canada. anne.bassett@utoronto.ca.